2021 annual financial data
Grace Therapeutics 2021 Operating cash flow margin
Grace Therapeutics 2021 operating cash flow margin with verified reported value…
Direct answer
Operating cash flow margin was -5,815.44%.
Operating income was -25,911,738 USD and net income was -31,054,946 USD.
Operating cash flow was -17,988,196 USD.
Get free Grace Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 309,318 USD
- Operating income
- -25,911,738 USD
- Net income
- -31,054,946 USD
- Operating cash flow
- -17,988,196 USD